TECHWIRE 30
(CIX: WRAL30)  1,126.59  up arrow+2.55  (0.23 %)  Updated: 08:10 PM EST, Dec 19 2014
(NQ: Apple)  111.78  down arrow-0.87  (-0.77 %)  Updated: 08:10 PM EST, Dec 19 2014
(NY: QUINTILES)  60.39  up arrow+1.01  (1.7 %)  Updated: 06:40 PM EST, Dec 19 2014
(OP: BASF SE)  85.15  down arrow-1.55  (-1.78 %)  Updated: 05:20 PM EST, Dec 19 2014
(NQ: BioCryst)  11.16  up arrow+0.08  (0.68 %)  Updated: 08:10 PM EST, Dec 19 2014
(NQ: BioDelivery)  13.82  up arrow+0.76  (5.82 %)  Updated: 08:10 PM EST, Dec 19 2014
(NQ: CEMP)  21.31  up arrow+0.8  (3.9 %)  Updated: 08:10 PM EST, Dec 19 2014
(NQ: Cisco Systems)  27.77  up arrow+0.12  (0.43 %)  Updated: 08:10 PM EST, Dec 19 2014
(NQ: Cree)  31.21  up arrow+0.31  (1 %)  Updated: 08:10 PM EST, Dec 19 2014
(NQ: DARA)  0.88  up arrow+0.04  (4.3 %)  Updated: 08:10 PM EST, Dec 19 2014
(NY: EMC CORPORATION)  30.14  up arrow+0.19  (0.63 %)  Updated: 06:40 PM EST, Dec 19 2014
(NQ: Extreme Networks)  3.44  up arrow+0.09  (2.69 %)  Updated: 08:10 PM EST, Dec 19 2014
(NQ: FB)  79.88  up arrow+1.48  (1.89 %)  Updated: 08:10 PM EST, Dec 19 2014
(NY: GLAXOSMITHKLINE)  43.35  up arrow+0.06  (0.14 %)  Updated: 06:40 PM EST, Dec 19 2014
(NQ: GOOG)  516.35  up arrow+5.25  (1.03 %)  Updated: 08:10 PM EST, Dec 19 2014
(NY: IBM)  158.51  up arrow+0.83  (0.53 %)  Updated: 06:40 PM EST, Dec 19 2014
(NY: LH)  105.80  down arrow-0.64  (-0.6 %)  Updated: 06:40 PM EST, Dec 19 2014
(OP: Lenovo Group)  26.38  up arrow+0.82  (3.21 %)  Updated: 05:20 PM EST, Dec 19 2014
(NY: MRK)  59.58  up arrow+0.6  (1.02 %)  Updated: 06:40 PM EST, Dec 19 2014
(NQ: Microsoft Corp)  47.66  up arrow+0.14  (0.29 %)  Updated: 08:10 PM EST, Dec 19 2014
(NQ: NTAP)  42.94  up arrow+0.22  (0.52 %)  Updated: 08:10 PM EST, Dec 19 2014
(NY: NOVARTIS AG)  94.61  up arrow+0.04  (0.04 %)  Updated: 06:40 PM EST, Dec 19 2014
(OP: Novozymes A/S)  43.11  down arrow-0.32  (-0.73 %)  Updated: 05:20 PM EST, Dec 19 2014
(NY: PFIZER)  31.94  down arrow-0.03  (-0.09 %)  Updated: 06:40 PM EST, Dec 19 2014
(NQ: Pozen)  8.17  up arrow+0.27  (3.42 %)  Updated: 08:10 PM EST, Dec 19 2014
(NY: RED HAT)  68.04  up arrow+6.54  (10.63 %)  Updated: 06:40 PM EST, Dec 19 2014
(NQ: BBRY)  9.99  down arrow-0.08  (-0.79 %)  Updated: 08:10 PM EST, Dec 19 2014
(NQ: Salix)  117.20  down arrow-1.25  (-1.06 %)  Updated: 08:10 PM EST, Dec 19 2014
(NQ: SQI)  14.97  down arrow-0.09  (-0.6 %)  Updated: 08:10 PM EST, Dec 19 2014

Posts tagged “Duke”

March 7, 2002

Premium Lock Expression Analysis Strikes Duke Deal, Closing $1 Million in Angel Funding

Expression Analysis, a start-up incubated by Durham-based Analytical Sciences Inc., adds Duke to 20 paying customers. Company now seeking CEO, other employees to handle growth.

Tags: Duke
March 7, 2002

Premium Lock Expression Analysis Strikes Deal with Duke, Closing $1 Million in Angel Funding

Expression Analysis, a start-up incubated by Durham-based Analytical Sciences Inc., adds Duke to 20 paying customers. Company now seeking CEO, other employees to handle growth.

Tags: Duke
March 7, 2002

Premium Lock Expression Analysis Strikes Duke Collaboration, Closing $1 Million in Angel Funding

Expression Analysis, a start-up incubated by Durham-based Analytical Sciences Inc., adds Duke to 20 paying customers. Company now seeking CEO, other employees to handle growth.

Tags: Duke
March 7, 2002

Premium Lock Expression Analysis Strikes Duke Collaboration, Closing $1 Million in Angel Funding by End of March

Expression Analysis, a start-up incubated by Durham-based Analytical Sciences Inc., adds Duke to 20 paying customers. Company now seeking CEO, other employees to handle growth.

Tags: Duke
March 6, 2002

Premium Lock Sitting on $900 Million: After 2001 Bust, Southeast VCs Hoarding the Cash

Investors in Georgia, NC say they want to see more good ideas and a better economy to pump up their return on investment. 'Returns will continue to suffer in the short term,' says Intersouth's Mitch Mumma.

March 5, 2002

Premium Lock Hey Is Back in the Saddle at MDeverywhere, Taking Over as CEO

Company insists move to replace Alan Rubin is 'amicable', adds that Rubin 'will be resigning' in next few days. Hey plans aggressive growth for company he founded.

Tags: Duke
February 27, 2002

Premium Lock Shocker: Paradigm Terminates Founder and CEO John Ryals; He Calls It 'Power Play'

Company sites no reason for dismissal. Ryals mum on next steps but hints at litigation. Biotech community stunned by the decision announced late Monday.

February 27, 2002

Premium Lock Paradigm Genetics Terminates Founder, President and CEO John Ryals

No reason cited for Ryal's ouster. Stock price had been dropping. Ryals and other execs have been selling stock. And the company has said Ryals was essential to its success, insuring him for $2 million.

Tags: Duke
February 26, 2002

Premium Lock Blue Diamond Awards Highlight Best in Charlotte High-Tech

MobileHWY, V3 Systems Among Headliners at Charlotte Chamber's Information Technology Council Awards. Ten Companies Take Home Honors.

February 25, 2002

Premium Lock Heart Disease Is Initial Focus of Paradigm-Duke Collaboration; Salix Submits New Drug Application

Paradigm Genetics, Duke sign a multi-year agreement to study the biochemistry of cells looking for clues to new treatments for multiple illnesses. <b>Also: </b>Salix submits NDA for traveler's diarrhea treatment.

Tags: Duke
February 22, 2002

Premium Lock Adult Stem Cell Progress Seems To Bolster Fortunes of Three Local Firms

Researchers at Duke and the University of Minnesota report exciting findings in adult stem cell experiments. To three Triangle companies - StemCo., Artecel, and Incara - that's good news.

February 18, 2002

Premium Lock CED Chooses 28 N.C. Firms To Make Pitch at Venture 2002 Conference

Firms cover an array of life sciences, hardware, software, telecommunications and online services. Investors from across the Southeast are expected to attend. 'We get to see a whole lot of people at once,' executive from presenting company says.

February 16, 2002

Premium Lock Bridging the Gap Between Charlotte and RTP?

Can Charlotte, RTP, other parts of NC find common ground to help state succeed as a biotech leader? UNC-Charlotte, bolstered recently by a $2.25 million NIH grant, intends to be a player on its own.

February 13, 2002

Premium Lock VC Profile: Aurora's Co-Founders Aggressively Build $70 Million Fund in Just Three Years

Sweet spot for investments: Seed and early stage life-science and information technology deals in the Southeast. But Aurora will make deals elsewhere, as the record shows.

February 12, 2002

Premium Lock Scientists Must Address People's Ethical and Moral Concerns as Well as Desire for New Drugs, Experts

'Just because you're pursuing good science doesn't guarantee acceptance,' NCSU professor warns at Emerging Issues Forum. NC Biotech president calls for 'investment" in dealing with public's worries up front.

Techwire Inside Partners
The Skinny: A Blog by Rick Smith

OUR INSIDERS

Dr. Mike Walden
Tech economy
Vivek Wadhwa
Commentary
Frank Vinluan
Life science
Scroll